The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Lilly; Merck; Roche
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Ipsen (Inst); Roche (Inst)
TTF-1 negativity as a biomarker of outcomes to immunotherapy, chemoimmunotherapy, and KRAS G12C inhibitors in lung adenocarcinoma.
 
Alessandro Di Federico
No Relationships to Disclose
 
Lingzhi Hong
No Relationships to Disclose
 
Arielle Elkrief
Honoraria - Astrazeneca; Bristol-Myers Squibb; Merck
Consulting or Advisory Role - Bristol Myers Squibb
Other Relationship - Canadian Institutes of Health Research (CIHR); Cedars Cancer Center; Royal College of Surgeons and Physicians of Canada
 
Rohit Thummalapalli
No Relationships to Disclose
 
Alissa Jamie Cooper
Honoraria - MJH Life Sciences
Consulting or Advisory Role - Gilead Sciences
Travel, Accommodations, Expenses - Gilead Sciences
 
Narek Shaverdian
Research Funding - Novartis (Inst); Oncohost (Inst)
 
Biagio Ricciuti
Honoraria - Targeted Oncology
Consulting or Advisory Role - Amgen; AstraZeneca; Guidepoint Inc; Regeneron
 
Joao Victor Machado Alessi
No Relationships to Disclose
 
Andrea De Giglio
No Relationships to Disclose
 
Federica Pecci
No Relationships to Disclose
 
Giuseppe Lamberti
No Relationships to Disclose
 
Malini Marion Gandhi
No Relationships to Disclose
 
Lynette M. Sholl
Stock and Other Ownership Interests - Moderna Therapeutics (I)
Consulting or Advisory Role - AstraZeneca; Genentech (Inst); Lilly (Inst)
Research Funding - Bristol Myers Squibb (Inst); Roche/Genentech (Inst)
 
Mizuki Nishino
Consulting or Advisory Role - AstraZeneca
Research Funding - Canon Medical System (Inst); Daiichi Sankyo (Inst); Konica Minolta (Inst)
 
Andrea Ardizzoni
No Relationships to Disclose
 
Rebecca Suk Heist
Consulting or Advisory Role - Abbvie; AstraZeneca; Claim Therapeutics; Daichii Sankyo; Daichii Sankyo; Lilly; Merck; Novartis; Regeneron; Sanofi
Research Funding - Abbvie (Inst); Agios (Inst); Corvus Pharmaceuticals (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Erasca, Inc (Inst); Exelixis (Inst); Exelixis (Inst); Lilly (Inst); Mirati Therapeutics (Inst); Mythic Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst); Roche (Inst); Turning Point Therapeutics (Inst)
 
Kathryn C. Arbour
Consulting or Advisory Role - Amgen; AstraZeneca; Genzyme; Lilly; Novartis; Revolution Medicines; Sanofi
Research Funding - Genentech (Inst); Mirati Therapeutics (Inst); Revolution Medicines (Inst)
Travel, Accommodations, Expenses - Revolution Medicines
 
Adam Jacob Schoenfeld
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Enara Bio; Heat Biologics; Immunocore; Iovance Biotherapeutics; Johnson & Johnson/Janssen; KSQ Therapeutics; Legend Biotech; Lyell Immunopharma; Merck; Oppenheimer; Perceptive Advisors; Prelude Therapeutics; Umoja Biopharma
Research Funding - Achilles Therapeutics; Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Harpoon therapeutics; Instil Bio; Iovance Biotherapeutics; Merck; PACT Pharma
Travel, Accommodations, Expenses - Instil Bio; Iovance Biotherapeutics
Other Relationship - Achilles Therapeutics; Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Harpoon therapeutics; Instil Bio; Iovance Biotherapeutics; Merck; PACT Pharma
 
Natalie I Vokes
Honoraria - Sanofi
Consulting or Advisory Role - Amgen; AstraZeneca; EMD Serono; Lilly; OncoCyte; Pfizer; Regeneron; Remedy Health; Sanofi; Sanofi/Regeneron; Summit pharmaceuticals; Tempus; Xencor
Research Funding - Circulo; Mirati Therapeutics; OncoCyte
Travel, Accommodations, Expenses - Regeneron
 
Mark M. Awad
Consulting or Advisory Role - Affini-T Therapeutics; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; EMD Serono; Foundation Medicine; Gritstone Bio; Instil Bio; Janssen; Merck; Mirati Therapeutics; Novartis; Pfizer; Regeneron
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst)
Travel, Accommodations, Expenses - Bristol Myers Squibb Foundation